-- Tianjin Pharmaceuticals Da Ren Tang's (SGX:T14) net attributable profit to owners during the first quarter of the year jumped by 13% to 423.8 million yuan from 374.2 million yuan a year earlier, according to a Wednesday filing with the Singapore Exchange.
Shares of the pharmaceutical company rose nearly 5% in Thursday trading.
Earnings per share came in at 0.55 yuan compared with 0.49 yuan in the year-ago period.
Revenue increased by 4% year over year to 1.52 billion yuan from 1.46 billion yuan, backed by increased revenue from major product lines.